<div id="readability-page-1"><div><p><span>Gibson Christopher Chief Executive Officer of Recursion Pharmaceuticals Inc [RXRX] filed a Form 4 on November 19, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>11/17/25</span></td><td><span>Surrender(1)</span></td><td><span>40,390</span></td><td><span>$4.14</span></td><td><span>$167,215</span></td></tr><tr><td><span>11/19/25</span></td><td><span>Planned Sale(2)</span></td><td><span>40,000</span></td><td><span>$4.16</span></td><td><span>$166,400</span></td></tr></tbody></table></div><p><span>Ending Holdings: 913,839 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</span></td></tr><tr><td><span>(2)</span></td><td><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

RXRX

<p>CEO Gibson Christopher of Recursion Pharmaceuticals Inc [RXRX] sold 40,000 shares worth $166,400 on November 19, 2025, as disclosed in a Form 4 filing with the SEC. The sale was executed under a prearranged trading plan (10b5-1).</p>

CEO Gibson Sells 40,000 ($166.4K) Of Recursion Pharmaceuticals Inc [RXRX]